Global Celiac Disease Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Celiac Disease Market Analysis

  • Pharmaceutical
  • Upcoming Report
  • Dec 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Celiac disease is an autoimmune illness in which a protein called gluten damages the small intestine's membrane. Gluten can be present in grains such as rye, barley, and wheat. Gluten causes an immunological reaction that damages the villi in the small intestine (small finger-like projections in the small intestine which promote absorption). The body's ability to absorb proteins, nutrients, lipids, vitamins, carbs, and minerals is hampered by the damage. This eventually leads to malnutrition.

Filled Map Analysis

Frequently Asked Questions

The market is segmented based on Segmentation, By Treatment (Infliximab, Larazotide Acetate, Gluten Free Diet, Others), Route of Administration (Oral, Parenteral), End Users (Hospitals, homecare, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)-Industry Trends and Forecast to 2032 .
The Global Celiac Disease Market size was valued at USD 968.81 USD Million in 2024.
The Global Celiac Disease Market is projected to grow at a CAGR of 10.4% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.